Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 9 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Merck's KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy -January 27, 2024 at 10:01 am EST

KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival with adjuvant therapy compared to placebo in patients with RCC Late-breaking OS results selected for the official...
United States Tonik Choueiri Nancy Kohlberg Harvard Medical School Exchange Commission Asco Gu Press Program

Merck's KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) as Adjuvant Therapy Versus Observation in High-Risk Patients With Localized Muscle-Invasive and Locally Advanced Urothelial Carcinoma After Surgery -January 26, 2024 at 10:01 am EST

KEYTRUDA doubled median DFS as adjuvant therapy versus observation โ€“ 29 months versus 14 months โ€“ in these patients AMBASSADOR /KEYNOTE-123 is the first positive trial for KEYTRUDA as adjuvant...
United States Merck Co Inc Alliance For Clinical Trials In Oncology Development Agreement Statement Of Merck Co Inc Merck Research Laboratories

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure

SOUTH PLAINFIELD, N.J., Jan. 25, 2024 /PRNewswire/ --ย PTC Therapeutics, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a...
United States Jeanine Clemente Kylie Okeefe Matthewb Klein Committee For Medicinal Products Human Use Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science